Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models

被引:226
作者
Chrast, Roman [1 ]
Saher, Gesine [2 ]
Nave, Klaus-Armin [2 ]
Verheijen, Mark H. G. [3 ]
机构
[1] Univ Lausanne, Dept Med Genet, CH-1015 Lausanne, Switzerland
[2] Max Planck Inst Expt Med, Dept Neurogenet, Gottingen, Germany
[3] Vrije Univ Amsterdam, Ctr Neurogenom & Cognit Res, Dept Mol & Cellular Neurobiol, Amsterdam, Netherlands
基金
瑞士国家科学基金会;
关键词
LEMLI-OPITZ-SYNDROME; SJOGREN-LARSSON-SYNDROME; PERIPHERAL NERVOUS-SYSTEM; FATTY-ACID COMPOSITION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PYRUVATE-CARBOXYLASE DEFICIENCY; GENOTYPE-PHENOTYPE CORRELATION; COA REDUCTASE INHIBITOR; LIVER PLASMA MEMBRANES; NIEMANN-PICK-DISEASE;
D O I
10.1194/jlr.R009761
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The integrity of central and peripheral nervous system myelin is affected in numerous lipid metabolism disorders. This vulnerability was so far mostly attributed to the extraordinarily high level of lipid synthesis that is required for the formation of myelin, and to the relative autonomy in lipid synthesis of myelinating glial cells because of blood barriers shielding the nervous system from circulating lipids. Recent insights from analysis of inherited lipid disorders, especially those with prevailing lipid depletion and from mouse models with glia-specific disruption of lipid metabolism, shed new light on this issue. The particular lipid composition of myelin, the transport of lipid-associated myelin proteins, and the necessity for timely assembly of the myelin sheath all contribute to the observed vulnerability of myelin to perturbed lipid metabolism. Furthermore, the uptake of external lipids may also play a role in the formation of myelin membranes. jlr In addition to an improved understanding of basic myelin biology, these data provide a foundation for future therapeutic interventions aiming at preserving glial cell integrity in metabolic disorders.-Chrast, R., G. Saher, K-A. Nave, and M. H. G. Verheijen. Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models. J. Lipid Res. 2011. 52: 419-434.
引用
收藏
页码:419 / 434
页数:16
相关论文
共 180 条
  • [21] Safety of statins
    Brown, William Virgil
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2008, 19 (06) : 558 - 562
  • [22] Brun N, 1999, AM J MED GENET, V84, P94, DOI 10.1002/(SICI)1096-8628(19990521)84:2<94::AID-AJMG3>3.3.CO
  • [23] 2-T
  • [24] Variations on a gene:: Rare and common variants in ABCA1 and their impact on HDL cholesterol levels and atherosclerosis
    Brunham, Liam R.
    Singaraja, Roshni R.
    Hayden, Michael R.
    [J]. ANNUAL REVIEW OF NUTRITION, 2006, 26 : 105 - 129
  • [25] MRI and 1H MRS findings in Smith-Lemli-Opitz syndrome
    Caruso, PA
    Poussaint, TY
    Tzika, AA
    Zurakowski, D
    Astrakas, LG
    Elias, ER
    Bay, C
    Irons, MB
    [J]. NEURORADIOLOGY, 2004, 46 (01) : 3 - 14
  • [26] CESAR M, 1995, J NEUROCHEM, V64, P2312
  • [27] Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis:: evidence for myelin-associated aspartoacylase
    Chakraborty, G
    Mekala, P
    Yahya, D
    Wu, GS
    Ledeen, RW
    [J]. JOURNAL OF NEUROCHEMISTRY, 2001, 78 (04) : 736 - 745
  • [28] THE SMITH-LEMLI-OPITZ SYNDROME - A DETAILED PATHOLOGICAL-STUDY AS A CLUE TO A ETIOLOGICAL HETEROGENEITY
    CHERSTVOY, ED
    LAZJUK, GI
    OSTROVSKAYA, TI
    SHVED, IA
    KRAVTZOVA, GI
    LURIE, IW
    GERASIMOVICH, AI
    [J]. VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1984, 404 (04) : 413 - 425
  • [29] Complement factors in adult peripheral nerve: a potential role in energy metabolism
    Chrast, R
    Verheijen, MHG
    Lemke, G
    [J]. NEUROCHEMISTRY INTERNATIONAL, 2004, 45 (2-3) : 353 - 359
  • [30] DHCR7 mutations and genotype-phenotype correlation in 37 Polish patients with Smith-Lemli-Opitz syndrome
    Ciara, E
    Nowaczyk, MJM
    Witsch-Baumgartner, M
    Malunowicz, E
    Popowska, E
    Jezela-Stanek, A
    Piotrowicz, M
    Waye, JS
    Utermann, G
    Krajewska-Walasek, M
    [J]. CLINICAL GENETICS, 2004, 66 (06) : 517 - 524